Study Design. Two groups of patients with chronic low back pain (cLBP) were scanned with functional magnetic resonance imaging during stimulation of the lower back; those showing 4 or 5 positive Waddell signs (WS-H) and those showing 1 or none (WS-L) as an index of painrelated illness behavior.
There are significant variations in how patients cope with chronic low back pain (cLBP); some patients seemingly manage normal lives whereas others develop considerable disability. Similarly, behavior in relation to pain (often referred to as "pain behavior" or "illness behavior") varies greatly across the cLBP population and excessive amounts of pain behavior may represent a major lack of adjustment by the patient to their pain. Most cases are idiopathic with structural or psychosocial determinants explaining only a small part of the variance of pain intensity or disability.
1 By contrast, brain imaging studies have revealed pathophysiological mechanisms present in patients with cLBP. [2] [3] [4] [5] [6] While these studies do not address pain behavior as such, they highlight the potential of functional alterations in the brains of cLBP patients contributing to both the chronicity of pain and associated behavioral attributes. In a magnetoencephalography study, stimulation of the lower back revealed a medial displacement of peak activation in the somatosensory cortex of patients with pain of the longest duration. 3 In another study, activation of the "emotional brain" in response to thermal stimulation of the lower back was seen. 6 Other groups have shown loss of gray matter in the prefrontal and somatosensory cortex. 7, 8 While all these studies provide convergent evidence of the presence of cerebral pathophysiology, none of them were designed to look for clinically important behavioral correlates in the cLBP population. It is widely acknowledged that patients show highly variable pain behavior in the clinic. The significance of such behavior was recognized over 2 decades ago by Waddell et al 9 who developed an instrument to clinically assess this aspect in patients with cLBP. The aim of the present study was to seek an answer to the question of whether this behavior is linked to differences in the cerebral processing of sensory signals coming from the lower back.
In aberrant pain behavior, 3 main components can be identified: first, nonpainful sensory signals are experienced and reported as painful. Second, exaggerated behavior is manifested in response to painful stimuli compared with what is commonly seen in people subjected to similar levels of pain. Third, there is an inability to tolerate activity, which may produce pain, leading to minimization of any activity judged as potentially inducing pain. In this study we explored 3 options in 2 groups of cLBP patients and healthy controls: that nonpainful sensory signals from the lower back are received or processed differently with excessive activation of the "pain matrix" in patients displaying major pain behavior, that the emotional circuitry of the brain is activated more in the same group, and that those not showing pain behavior and coping well despite their back pain show increased activation in regions that direct pain modulation. In addition, we explored the possibility that the groups differed in the extent to which their somatosensory cortex shows neuronal reorganization, as seen previously in low back pain. 3 In this study, clinical judgment on pain behavior was made on the basis of Waddell signs (WS). Although WS do not imply a nonorganic versus organic pathology they form a yardstick to clinically assess behavioral features in a patient that can help therapeutic decision-making. These clinical signs have been validated and shown to be reproducible. 10 Waddell and others originally proposed that WS could draw attention to the possibility of exaggerated illness behavior (defined as "maladaptive overt illness-related behavior which is out of proportion to the underlying physical disease and more readily attributable to associated cognitive and affective disturbance" 11 ). Subsequent studies have shown that high scores of WS are associated with poor physical performance, increased catastrophizing and poor treatment outcome. 12 Low scorers are no different from healthy subjects, indicating that they have developed techniques enabling them to cope in everyday situations without overt pain behavior.
Materials and Methods

Participants
Thirty cLBP patients [16 men; 14 women, aged between 21 and 67 years with a mean age of 45 years (SD ϭ 12.
2)] and 17 healthy controls [8 men; 9 women, aged between 25 and 53 years, mean age 31 years (SD ϭ 8.1)] were recruited for the study. (Because of problems with the stimulation equipment, data were successfully acquired for 28 patients). Patients with a history of major neurological or psychiatric disease, head trauma, current drug or alcohol abuse or evidence of cognitive decline were excluded. The study had ethics committee approval and all participants gave informed written consent. Patients were examined independently by a spinal surgeon (G.F.) and a pain specialist (T.N.) for Waddell signs. Those with a low positive score (0 -1 out of the 5 categories), were considered to show no pain behavior (WS-L), while patients with a high score (4 -5 out of 5), were considered to represent a group with major pain behavior (WS-H). No patient with an intermediate score (i.e., 2-3/5) was entered into the study. Inclusion criteria were: pain over 6 months; mechanical axial back pain without sciatica (referred pain to posterior thigh allowed if less intense than lower back pain); no previous operations for back pain (including facet denervation); magnetic resonance imaging (MRI) showing no structural spinal abnormality other than degenerative change in no more than three lumbar discs and straight leg raise associated with back pain (not leg pain). Patients were allowed to continue on stable medication, including opioids with an arbitrarily set highest accepted dose of 60mg of morphine per day (or an equivalent dose of an alternative opioid). Paracetamol (acetaminophen) was allowed within recommended doses (up to 4000 mg/day) as were low doses of antidepressants and antiepileptic drugs (e.g., amitriptyline 35 mg/ day, gabapentin 1200 mg/day).
Methods
To deliver intense tactile stimulation to the participants' lower back a custom-made contact plate was designed that was safe to use in the MR environment and did not result in degradation of the quality of the MR image. This was controlled by a Thandor TG503 5 MHz Pulse/Function Generator with a Digitimer Constant Current Stimulator (model D57A) to deliver the same frequency of stimulation (0.25 Hz) at a tolerance threshold determined for each subject. All patients had normal cutaneous sensation in the lower back as determined by the examining specialists.
Immediately before functional MRI (fMRI) scanning participants were tested for their individual lumbar stimulation tolerance threshold (LSTT). While inside the scanner room the contact plate was placed on the participant's lower back after which they lay horizontally on the scanner bed securing the plate in place. The intensity of stimulation (measured in mA) was increased manually by the experimenter starting at 0 mA (reaching a maximum of 14.5 mA). The stimulus was perceived to be an intense and unpleasant but nonpainful slow wave vibration.* Intensity was rated numerically by participants from 0 (no stimulation) until it reached a level of 7 of 10 (the point at which the participant did not wish the intensity of the stimulus to increase any further). This procedure was repeated and the final value was then taken as the participant's LSTT for the fMRI scan.
Participants were also asked to complete several questionnaires. This included the visual analogue scale (VAS 13 ), scoring how much low back pain they were currently experiencing (VAS now ) or the average pain experienced in the last 5 days (VAS 5Day ); the Pain Coping Strategies Questionnaire 14 ; the activities subscale of the Fear Avoidance Beliefs Questionnaire 15 and the Hospital Anxiety and Depression Scale. 16 Healthy controls were only required to complete the VAS and Hospital Anxiety and Depression Scale to confirm they did not have significant levels of pain, anxiety or depression. As predicted, scores on these measures were normal for the population and are not considered further.
During the fMRI scan stimulation was alternated with periods of rest (no stimulation) in an ABAB blocked design where A ϭ rest (duration 15 seconds) and B ϭ stimulation (duration 15 seconds). The total scan time was 5 minutes 15 seconds. Participants were instructed to focus on the sensation occurring on the lower back throughout the scan. Whole brain fMRI was carried out on a 1.5T General Electric Signa LX/Nvi scanner using the blood oxygenation leveldependent contrast technique. Data were analyzed within the *We purposefully chose an intense, inherently unpleasant stimulus deemed sufficient to activate the common nociception processing circuitry at subliminal levels (revealing excessive pain-related activation in either group) and invoke attentional and cognitive circuitries responsible for modulation of painful and non-painful sensation without causing undue discomfort and subsequent movement.
general linear model as implemented in FEAT5 software, part of the FMRIB Software Library. 17 Preprocessing steps included motion correction, spatial smoothing, mean-based intensity normalization, and nonlinear high-pass temporal filtering. Contrast images for each subject were computed and transformed into MNI standard space. 18 Group-wise independent t tests were performed to determine the difference in activation to stimulation of the lower back between patient groups and between patients and healthy controls in a mixed effects model. Z statistical images were thresholded at Z Ͼ2.3 and cluster corrected for multiple comparisons at P ϭ 0.05 (details of data acquisition and analysis are available online through Article Plus).
Results
General
Fifteen patients met the criteria for WS-L and 13 for WS-H. The mean difference in age (1 SD) between patient groups was nonsignificant (WS-H mean ϭ 44 (11.7) years; WS-L mean ϭ 46 (13.3) years; P ϭ 0.586) as was the difference in mean chronicity of low back pain (WS-H mean ϭ 112 (86.7) months; WS-L mean ϭ 123 (115) months; P ϭ 0.801). However, the difference in age between both patient groups and healthy controls was significant (control mean ϭ 31 (2.0) years; P Ͻ 0.01). Ongoing stable medication did not differ substantially between groups with most patients taking NSAIDS (9 WS-H, and 4 WS-L patients) and paracetamol (7 WS-H and 5 WS-L patients). Eight patients in each group were on low doses of opioids; 1 patient in the WS-H group was on stable modified release morphine sulfate at 60 mg/day. None reported taking medication in excess of recommended doses.
Questionnaire Data
WS-H patients rated their own pain levels as significantly greater than WS-L patients on the VAS now (WS-H Mean ϭ 6.0 (1.6); WS-L Mean ϭ 3.7 (1.9); P ϭ 0.004) but not on the 5-day average (WS-H Mean ϭ 5.4 (2.9); WS-L Mean ϭ 5.1 (2.2); P ϭ 0.77). They also scored significantly higher on the catastrophizing subscale of the CSQ (WS-H Mean ϭ 19.2 (7.6); WS-L Mean ϭ 9.3 (7.0); P ϭ 0.006) but not on any other measure (all P's Ͼ.05). WS-H patients rated their depression levels significantly higher than WS-L patients (WS-H Mean ϭ 10.3 (3.2); WS-L Mean ϭ 7.0 (4.0); P ϭ0.038) but not their anxiety levels (WS-H Mean ϭ 11.0 (3.7); WS-L Mean ϭ 9.5 (4.2); P ϭ 0.380) and showed only a nonsignificant trend towards an increased score on the Fear Avoidance Beliefs Questionnaire activities subscale (WS-H Mean ϭ 19.6 (8.2); WS-L Mean ϭ 14.0 (6.4); P ϭ 0.078).
Lumbar Stimulation Tolerance Threshold
Independent t tests revealed no significant difference in mean LSTT between the 3 groups (WS-H ϭ 7.3 (2.2) mA; WS-L ϭ 8.4 (3.5) mA; Controls ϭ 8.6 (3.4) mA; all comparisons P Ͼ 0.05). Post hoc comparisons found no evidence of a significant difference in mean LSTT between males and females in our cohort of healthy controls (Males ϭ 9.5 (3.4) mA; Females ϭ 7.9 (3.3) mA; P ϭ 0.346) or in the WS-H patient group (WS-H males ϭ 7.1 (2.4) mA; WS-H females ϭ 7.5 (2.2) mA; P ϭ 0.754) with a just significant difference in the WS-L group (WS-L males ϭ 9.8 (3.4) mA; WS-L females ϭ 6.3 (1.5) mA; P ϭ 0.041).
Within Group fMRI Data
Inclusive masking revealed activation common to all 3 groups in right anterior insula and right ventrolateral prefrontal cortex only. This was due to the fact that the WS-H group showed entirely right-lateralized activity in and around anterior insula and ventrolateral prefrontal cortex (BA44/45) to tactile stimulation of the lower back with no significant response in SI, SII or subcortical sites evident at this threshold (Table 1) .
In response to the same stimulus healthy controls showed additional activation of right SII (BA42) extending into parietal operculum and inferior parietal lobe (BA40) and SI (BA2) and in sites across insula cortex extending into sylvian fissure and anterior temporal pole (Table 1) . Subcortical activation was seen in brain stem including periaqueductal gray. In the WS-L group, in addition to activity in right ventrolateral prefrontal and insula cortices, bilateral activation was also seen in SI and SII and inferior parietal lobe (BA40; including supramarginal gyrus and ventral bank of sylvian fissure) and superior and medial frontal gyrus (BA8/9) extending into rostral anterior cingulate cortex (BA32). No subcortical activation was seen (Table 1) .
Between-Group fMRI Data
Compared with healthy controls, the WS-L group demonstrated significantly more activation in left superior parietal lobe (BA7; x,y,z ϭ Ϫ30, Ϫ72, 42 mm; Z ϭ 3.45) and left extrastriate visual cortex (BA18/19; x,y,z ϭ Ϫ40, Ϫ80, Ϫ16 mm; Z ϭ 3.08) including fusiform gyrus (BA37/18; x,y,z ϭ Ϫ40, Ϫ60, Ϫ10 mm; Z ϭ 3.45). There were no areas of increased activation in healthy controls versus WS-L patients and no significant differences in activation between healthy controls and the WS-H patients.
Compared with the WS-H patients the WS-L group also showed significantly more activation in midline retrosplenial cingulate cortex (BA23/31; peak of activation at x,y,z ϭ 4, Ϫ54, 18 mm; Z ϭ 3.23) extending on the right into striate (BA17; peak of activation at x,y,z ϭ 22, Ϫ66, 10 mm; Z ϭ 3.54) and extrastriate cortex (BA18; peak of activation at x,y,z ϭ 14, Ϫ76, 24 mm; Z ϭ 3.14; Figure 1 ). Left-lateralized activity was seen across inferior parietal cortex (BA40; x,y,z ϭ Ϫ46, Ϫ50, 42 mm; Z ϭ 3.36) extending into superior parietal lobe (BA7; x,y,z ϭ Ϫ38, Ϫ66, 38 mm; Z ϭ 3.08). A significant negative correlation between the magnitude of the blood oxygenation level-dependent response in these areas and scores on the catastrophizing subscale of the CSQ was identified (r ϭ Ϫ0.431, P ϭ 0.023). No other psychometric measures were related and there were no areas of increased activity in the WS-H patient group.
Evidence for Reorganization of Primary Somatosensory Cortex in cLBP
By reducing the group cluster-based threshold level to P Ͻ 0.05 (uncorrected) activation of SI was seen across all 3 groups corresponding to the expected somatotopic representation of the lower back (see Ref.
3 ). Figure 2 illustrates the position of this activation across 2 2-mm axial slices (starting at z ϭ 62 mm). Healthy controls show bilateral activation of SI with a peak in the left hemisphere at x,y,z ϭ Ϫ20, 43, 64 mm and in the right hemisphere at x,y,z ϭ 18, 44, 64 mm. The WS-H group had a discrete cluster of activity occurring entirely in the right hemisphere (7 voxels), with a peak at x,y,z ϭ 15, 46, 65 mm indicating a medial shift in the x direction of 3 mm and a posterior shift in the y direction of 2 mm. The WS-L patient group showed a much larger cluster of activity in the right hemisphere (23 voxels), with a peak at x,y,z ϭ 19, 35, 63 mm. Compared to the WS-L group, the WS-H group had a significant medial shift in the x-direction of 4 mm (P ϭ 0.001), a posterior shift in the ydirection of 9 mm (P Ͻ 0.001) and a dorsal shift in the z-direction of 2 mm (P ϭ 0.006).
Discussion
Group comparisons revealed no major difference between WS-H and WS-L groups in common painactivated cortical regions suggesting that pain behavior cannot be linked to excessive or reduced engagement of the pain matrix in either patient group. Similarly, we did not find preferential activation of the affective brain in WS-H patients. Our results are different from those of Baliki et al, 6 who showed increased activation in the medial prefrontal cortex and anterior cingulate cortex in a low back pain cohort compared with healthy volunteers. Methodologic factors, including the use in our study of a nonpainful stimulus, may account for this difference.
However, our finding of increased activation in right posterior (retrosplenial) cingulate and extrastriate cortex and left posterior parietal lobe in the WS-L versus WS-H patients ( Figure 2 ) suggests a fundamental difference between the 2 groups in their ability to process afferent sensory input from the lower back. These areas have previously been implicated in the top-down modulation of pain 19, 20 and may provide a mechanism of successful adjustment in those who cope well with the pain.
The posterior cingulate cortex is commonly activated during painful as well as emotional stimuli and, with the posterior parietal cortex, is likely involved in orienting towards innocuous and noxious somatosensory stimuli. 19, 20 Inputs from the dorsolateral prefrontal cortex (DLPFC) to posterior cingulate cortex may provide one mechanism by which WS-L patients effectively distract themselves from the signals arising from the lower back 21 as only the WS-L patient group showed increased suprathreshold activation of right DLPFC, an area believed to represent a reciprocal system for active inhibition of salient sensory information through "top-down" cognitive control via ACC. 22 The lack of DLPFC and ACC activation in the WS-H patients would therefore represent the inability to fully engage these cortical regions when needed and effectively control signals from the lower back leading to a more pronounced display of behavioral signs. The negative correlation with scores on the catastrophizing subscale of the CSQ in the WS-L group supports the view that successful activation of these regions may be associated with good coping and prevention of pain behavior.
The modest shift in the locus of primary somatosensory cortex activation seen in the WS-H patient group was expected and has been described before in both cLBP 3 and complex regional pain syndrome, 23 suggesting cortical reorganization as a response by particular populations of chronic patients to long-term nociceptive input. Unexpectedly, only healthy controls and WS-L patients activated SI bilaterally even though stimulation was bilateral and proximal structures (such as the trunk) have predominantly bilateral receptive fields. 24 It is possible that cortical dysfunction or even local atrophy has occurred in the WS-H patient group and this interpretation gains support from a recent study showing reduction in gray matter mass in somatosensory cortex in cLBP patients, which negatively correlated with the unpleasantness dimension of ongoing pain. 7 The patient's behavior in the clinic during testing for WS is the sum of 2 functions; quality and intensity of somatosensory signals arising from the lower back, and their cognitive-affective appraisal. In this study, we show increased processing in nonsensory specific cortex in WS-L compared with WS-H patients suggesting successful orientation to and top-down control of somatic information on the body. In clinical terms, the WS-L patients represent a welladjusted group confirmed by normal responses to Waddell tests and low levels of depression and catastrophizing with a capacity for effective endogenous pain modulation. This, rather than excessive engagement of regions that encode intensity and unpleasantness of pain predominantly separated the 2 groups. It should be pointed out that the design of the present study allows us to discuss cerebral responses to sensory stimulation only and not to tasks designed to elicit emotional reactions. The latter may be an equally fruitful avenue to explore in future studies. Nevertheless, if the present results can be corroborated, the next obvious question is whether a cognitive, behavioral, or pharmacological manipulation can be developed to specifically target the brain structures identified in our patients.
Key Points
• Patients with chronic low back pain show variable degrees of pain behavior.
• Patients coping well with none or 1 WS activate cortical regions critical for top-down modulation of painful and nonpainful sensation in response to low back stimulation. Figure 2 . Activation of primary somatosensory cortex (SI) in all 3 groups corresponding to the somatotopic representation of the back across 2 2-mm axial slices (starting at z ϭ 64 mm). Maps were cluster-based thresholded at P Ͻ 0.05 (uncorrected) and are shown in radiologic convention.
• Patients with high WS scores and elevated levels of catastrophizing lack this response but show more reorganization in primary somatosensory cortex.
Appendix available online through Article Plus.
